← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Net income decreased 40.6% to ($446.2M), while Operating cash flow decreased 37.9% to ($403.2M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue N/AWatch
- Profitability — Net income ($446.2M)Watch
- Cash generation — Free cash flow ($405.1M)Note
- Accounting — No applicable forensic screenNote
- Insiders — 3 buys; 31 sells in 365 daysOK
- Capital — Comparable payout data unavailableNote
Business
Dyne Therapeutics, Inc.: This Annual Report includes statistical and other industry and market data that we obtained from independent industry publications and research, surveys and studies conducted by independent third parties as well as our own estimates of the prevalence of certain diseases and conditions.
Leadership changes
From Dyne Therapeutics, Inc.'s own filings, the day they're filed.
- Erick Lucera · Chief Financial Officer · appointmenteff. 2025-03-31
- Susanna High · Chief Operating Officer · departureeff. 2024-09-03
- Joshua Brumm · director · appointmenteff. 2024-03-25
Latest filings
- 10-Q · Quarterly report2026-07-29
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-07-22
- 8-K · Company announcement2026-07-20
- 8-K · Company announcement2026-06-22
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Dyne Therapeutics, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.